American Parents Accelerate MMR Vaccinations Amid Rising Measles Infections

Confirmed measles cases across the United States have accelerated, reaching double the number recorded in the previous year. In response to the growing infection numbers, more parents are choosing to administer the second dose of the measles, mumps and rubella (MMR) vaccine earlier than the standard schedule.

The US Centers for Disease Control and Prevention typically recommends the first MMR shot after a child turns one year old, with the second dose given between the ages of four and six. However, the second dose can legally be given as soon as four weeks after the initial injection. This accelerated timeline aligns with recommendations in several other nations, including Germany, the United Kingdom and France.

Seattle naturopathic physician and vaccine advocate Elias Kass noted that an increasing number of parents are asking about early vaccination. Kass stated that he began recommending the combined MMRV shot at 15 months of age when measles cases started rising several years prior, noting that parents feel there is no reason to wait given current outbreaks.

Chicago mother Margot Taylor adjusted the vaccination timelines for her three children due to the escalating cases. While her oldest child received doses at ages one and four, her second child received the second shot at age two during a Chicago outbreak. Her third child received the second dose just three months after the first birthday in June.

While Taylor initially worried that earlier doses might be less effective, medical evidence indicates the vaccines remain effective when administered earlier. The conventional four-to-six-year window for the second dose is primarily based on logistical factors, ensuring children complete their vaccinations before entering kindergarten and reducing the number of clinical visits.

International health authorities have adapted their schedules in response to past outbreaks. Germany maintained guidelines similar to the US until an outbreak prompted policy adjustments, eventually recommending the second dose four weeks after the first by 2020.